Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alverine
2. Alverine Hydrochloride
3. Spasmaverine
4. Spasmonal
1. 5560-59-8
2. Alverine (citrate)
3. Antispasmin
4. Spacolin
5. Gamatran Citrate
6. Nsc 35459
7. Spasmaverine
8. Alverine Citrate Salt
9. Calmabel
10. Profenine
11. Prophelan
12. Proverine
13. Profenil Citrate
14. Nci 85x
15. Alverine Citrate [usan]
16. Nsc-35459
17. Phenpropamine Citrate
18. N-ethyl-3,3'-diphenyldipropylamine Citrate (1:1)
19. 9jfb58yk1e
20. Mls000069524
21. 5560-59-8 (citrate)
22. Chebi:53785
23. N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
24. Dipropylamine, N-ethyl-3,3'-diphenyl-, Citrate (1:1)
25. Ncgc00017047-01
26. Smr000058631
27. Cas-5560-59-8
28. Alverine Citrate (usan)
29. Benzenepropanamine, N-ethyl-n-(3-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
30. Dsstox_cid_25562
31. Dsstox_rid_80959
32. Dsstox_gsid_45562
33. Alverine Dihydrogen Citrate
34. N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid
35. Sr-01000003029
36. Unii-9jfb58yk1e
37. Alverine Citrate [usan:nf]
38. Prestwick_912
39. Einecs 226-929-3
40. Alverinecitrate
41. Opera_id_1477
42. Dipropylamine, N-ethyl-3,3'-diphenyl-, Citrate
43. N-ethyl-bis(3-phenylpropyl)amin-dihydrogencitrat
44. Mls001148462
45. Mls002207301
46. Mls002222279
47. Mls004712036
48. Alverine Citrate [mi]
49. Schembl352008
50. Spectrum1500109
51. Regid_for_cid_21718
52. Chembl1408594
53. Dtxsid3045562
54. Alverine Citrate [mart.]
55. Alverine Citrate [who-dd]
56. Hms1568d09
57. Hms1920a17
58. Hms2091g17
59. Hms2095d09
60. Hms2232d03
61. Hms3371i14
62. Hms3651f18
63. Hms3712d09
64. Hms3885o05
65. Pharmakon1600-01500109
66. Hy-b0500
67. Tox21_110757
68. Dipropylamine,3'-diphenyl-, Citrate
69. Mfcd00035086
70. Nsc755859
71. S3054
72. Akos015895657
73. Tox21_110757_1
74. Alverine Citrate [ep Monograph]
75. Ccg-212472
76. Nsc-755859
77. Ncgc00017047-02
78. Ncgc00017047-03
79. Ncgc00021122-08
80. Ncgc00094581-01
81. Ncgc00094581-02
82. As-56723
83. Db-052764
84. N-ethyl-3,3'-diphenyldipropylamine Citrate
85. Dipropylamine,3'-diphenyl-, Citrate (1:1)
86. Ft-0622247
87. Sw197030-3
88. A16396
89. D02877
90. D84224
91. A830720
92. Sr-01000003029-2
93. Sr-01000003029-4
94. Q27124210
95. Benzenepropanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
96. Citric Acid; N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine
97. 2-hydroxypropane-1,2,3-tricarboxylic Acid; Ethylbis(3-phenylpropyl)amine
98. Alverine Citrate Salt, European Pharmacopoeia (ep) Reference Standard
99. Alverine For Peak Identification, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 473.6 g/mol |
|---|---|
| Molecular Formula | C26H35NO7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 14 |
| Exact Mass | 473.24135246 g/mol |
| Monoisotopic Mass | 473.24135246 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 442 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Alverine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alverine, including repackagers and relabelers. The FDA regulates Alverine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alverine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alverine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alverine supplier is an individual or a company that provides Alverine active pharmaceutical ingredient (API) or Alverine finished formulations upon request. The Alverine suppliers may include Alverine API manufacturers, exporters, distributors and traders.
click here to find a list of Alverine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alverine DMF (Drug Master File) is a document detailing the whole manufacturing process of Alverine active pharmaceutical ingredient (API) in detail. Different forms of Alverine DMFs exist exist since differing nations have different regulations, such as Alverine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alverine DMF submitted to regulatory agencies in the US is known as a USDMF. Alverine USDMF includes data on Alverine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alverine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alverine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alverine Drug Master File in Korea (Alverine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alverine. The MFDS reviews the Alverine KDMF as part of the drug registration process and uses the information provided in the Alverine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alverine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alverine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alverine suppliers with KDMF on PharmaCompass.
Alverine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alverine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alverine GMP manufacturer or Alverine GMP API supplier for your needs.
A Alverine CoA (Certificate of Analysis) is a formal document that attests to Alverine's compliance with Alverine specifications and serves as a tool for batch-level quality control.
Alverine CoA mostly includes findings from lab analyses of a specific batch. For each Alverine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alverine may be tested according to a variety of international standards, such as European Pharmacopoeia (Alverine EP), Alverine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alverine USP).
LOOKING FOR A SUPPLIER?
